Prenatal psychotropic drug exposure and the development of central dopaminergic and cholinergic neurotransmitter systems.
D000109:Acetylcholine / Q000502:physiology*; D000818:Animals; D001921:Brain / Q000254:growth & development*; D003342:Corpus Striatum / Q000032:analysis; D004298:Dopamine / Q000502:physiology*; D005260:Female; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D011619:Psychotropic Drugs / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D011950:Receptors, Cholinergic / Q000032:analysis; D011954:Receptors, Dopamine / Q000032:analysis; D011976:Receptors, Muscarinic / Q000032:analysis; D009435:Synaptic Transmission / Q000187:drug effects*
D011619:Psychotropic Drugs; D011950:Receptors, Cholinergic; D011954:Receptors, Dopamine; D011976:Receptors, Muscarinic; D000109:Acetylcholine; D004298:Dopamine